A detailed history of Primecap Management CO transactions in Amgen Inc stock. As of the latest transaction made, Primecap Management CO holds 14,255,941 shares of AMGN stock, worth $4.1 Billion. This represents 3.44% of its overall portfolio holdings.

Number of Shares
14,255,941
Previous 14,447,127 1.32%
Holding current value
$4.1 Billion
Previous $4.51 Billion 1.76%
% of portfolio
3.44%
Previous 3.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$309.38 - $337.38 $59.1 Million - $64.5 Million
-191,186 Reduced 1.32%
14,255,941 $4.59 Billion
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $40.7 Million - $49.4 Million
-154,831 Reduced 1.06%
14,447,127 $4.51 Billion
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $2.82 Million - $3.4 Million
10,490 Added 0.07%
14,601,958 $4.15 Billion
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $36.1 Million - $40.7 Million
-140,990 Reduced 0.96%
14,591,468 $4.2 Billion
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $869,571 - $1.08 Million
-3,977 Reduced 0.03%
14,732,458 $3.96 Billion
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $80.6 Million - $95.3 Million
-376,268 Reduced 2.49%
14,736,435 $3.27 Billion
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $40.5 Million - $49.4 Million
-179,510 Reduced 1.17%
15,112,703 $3.65 Billion
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $62.4 Million - $79.3 Million
-272,657 Reduced 1.75%
15,292,213 $4.02 Billion
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $16.6 Million - $18.7 Million
-73,750 Reduced 0.47%
15,564,870 $3.51 Billion
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $20.2 Million - $22.4 Million
-87,435 Reduced 0.56%
15,638,620 $3.8 Billion
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $11 Million - $12.2 Million
-50,100 Reduced 0.32%
15,726,055 $3.8 Billion
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $61 Million - $69.8 Million
-306,532 Reduced 1.91%
15,776,155 $3.55 Billion
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $35.3 Million - $41.4 Million
-166,385 Reduced 1.02%
16,082,687 $3.42 Billion
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $99.4 Million - $110 Million
-425,500 Reduced 2.55%
16,249,072 $3.96 Billion
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $67.5 Million - $78.7 Million
-304,255 Reduced 1.79%
16,674,572 $4.15 Billion
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $92.7 Million - $110 Million
-428,255 Reduced 2.46%
16,978,827 $3.9 Billion
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $130 Million - $145 Million
-555,848 Reduced 3.09%
17,407,082 $4.42 Billion
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $102 Million - $126 Million
-517,160 Reduced 2.8%
17,962,930 $4.24 Billion
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $33.4 Million - $44.2 Million
183,075 Added 1.0%
18,480,090 $3.75 Billion
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $18.2 Million - $23.4 Million
96,414 Added 0.53%
18,297,015 $4.41 Billion
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $74.6 Million - $89.4 Million
-428,322 Reduced 2.3%
18,200,601 $3.52 Billion
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $67.3 Million - $78.9 Million
-403,945 Reduced 2.12%
18,628,923 $3.43 Billion
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $147 Million - $166 Million
-813,348 Reduced 4.1%
19,032,868 $3.62 Billion
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $169 Million - $197 Million
-947,226 Reduced 4.56%
19,846,216 $3.86 Billion
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $70.5 Million - $79.4 Million
-380,302 Reduced 1.8%
20,793,442 $4.31 Billion
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $44.6 Million - $50.1 Million
-268,600 Reduced 1.25%
21,173,744 $3.91 Billion
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $99.6 Million - $116 Million
-587,905 Reduced 2.67%
21,442,344 $3.66 Billion
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $38.7 Million - $43.2 Million
-229,109 Reduced 1.03%
22,030,249 $3.83 Billion
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $3.72 Billion - $4.25 Billion
22,259,358
22,259,358 $4.15 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.